CD4 and COVID-19: The main cellular immunopathologic markers for the severe COVID-19 cases are a marked reduction in the number of monocytes as well as lymphocytopenia in addition to a substantial decrease in the numbers of all circulating lymphocyte subsets, including CD4+ T cells, CD8+ T cells, B cells, and natural killer (NK) cells.